• SPX
  • $5,917.11
  • 0 %
  • $0.13
  • DJI
  • $43,408.47
  • 0.32 %
  • $139.53
  • N225
  • $38,026.17
  • -0.85 %
  • -$326.17
  • FTSE
  • $8,110.03
  • 0.31 %
  • $24.96
  • IXIC
  • $18,966.14
  • -0.11 %
  • -$21.33
DURECT Corporation (DRRX) Stock Price, News & Analysis

DURECT Corporation (DRRX) Stock Price, News & Analysis

Currency in USD Disclaimer

$0.90

-$0.08

(-7.91%)

Day's range
$0.88
Day's range
$0.98
50-day range
$0.8164
Day's range
$1.65
  • Country: US
  • ISIN: US2666055007
52 wk range
$0.48
Day's range
$1.88
  • CEO: Dr. James E. Brown D.V.M.
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -36.42
  • Piotroski Score 1.00
  • Grade Neutral
  • Symbol (DRRX)
  • Company DURECT Corporation
  • Price $0.90
  • Changes Percentage (-7.91%)
  • Change -$0.08
  • Day Low $0.88
  • Day High $0.98
  • Year High $1.88

DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Santen Pharmaceutical Co., Ltd. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 11/13/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.93
  • Trailing P/E Ratio -1.63
  • Forward P/E Ratio -1.63
  • P/E Growth -1.63
  • Net Income $-27,624,000

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

DURECT Corporation Frequently Asked Questions

  • What were the earnings of DRRX in the last quarter?

    In the last quarter DURECT Corporation earnings were on Wednesday, November, 13th. The DURECT Corporation maker reported -$0.14 EPS for the quarter, beating analysts' consensus estimates of -$0.17 by $0.03.

  • What is the DURECT Corporation stock price today?

    Today's price of DURECT Corporation is $0.90 — it has decreased by -7.91% in the past 24 hours. Watch DURECT Corporation stock price performance more closely on the chart.

  • Does DURECT Corporation release reports?

    Yes, you can track DURECT Corporation's financials in yearly and quarterly reports directly on Stocks.News.

  • What is the DURECT Corporation stock forecast?

    Watch the DURECT Corporation chart and read a more detailed DURECT Corporation stock forecast to see what analysts suggest you do with its shares.

  • What is DURECT Corporation stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by DURECT Corporation stock ticker.

  • How to buy DURECT Corporation stocks?

    Like other stocks, DRRX shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is DURECT Corporation's EBITDA?

    DURECT Corporation measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in DURECT Corporation’s financial statements.

  • What is the DURECT Corporation's net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -3.2316331306, which equates to approximately -323.16%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in DURECT Corporation stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including DURECT Corporation's financials relevant news, and technical analysis. DURECT Corporation's technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for DURECT Corporation stock currently indicates a “sell” signal. For more insights, review DURECT Corporation’s technical analysis.

  • A revenue figure for DURECT Corporation for its last quarter?

    DURECT Corporation published it's last quarterly revenues at $1.93 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.